跳至主要内容
临床试验/NCT02880111
NCT02880111终止不适用

Comparison of Rates DMBT1 ( Glycoprotein) in Sputum of CF Patients Colonized Patients Between Chronic and Non-chronic Patients Colonized With Pseudomonas Aeruginosa

University Hospital, Lille1 个研究点 分布在 1 个国家目标入组 1 人开始时间: 2016年3月23日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
入组人数
1
试验地点
1
主要终点
measure glycoprotein-like DMBT1 by Elisa

研究概览

简要总结

Rates of DMBT1 (Glycoprotein like) in Sputum of CF Patients with or without may be different according to their Pseudomonas Aeruginosa chronic colonization status. The aim of this study is to compare rates of DMBT1 (Glycoprotein like) in Sputum of CF patients with or without a Pseudomonas Aeruginosa chronic colonization.

详细描述

Rates of DMBT1 (Deleted in Malignant Brain Tumor 1) will be compared between 2 groups of 30 CF patients : group 1 : with Pseudomonas Aeruginosa chronic colonization and group 2 30 CF patients without Pseudomonas Aeruginosa chronic colonization.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
6 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • CF patient 6 years
  • Availability of sputum
  • Signed Informed consent

排除标准

  • Cardiac insufficiency
  • Anti-inflammatory drugs on going
  • Oral corticosteroid therapy
  • Inhaled corticosteroids during the two weeks before inclusion,
  • Patient awaiting lung transplantation
  • Patient with a past history of heart/lung transplantation
  • Patient with a sputum examination positive for : atypical mycobacteria, Burkholderia cepacia, Stenotrophomonas maltophilia,
  • Patient chronically colonized with multiresistant Pseudomonas aeruginosa
  • Orkambi© or Kalydeco© therapy
  • Change of the CF treatment during the last 4 weeks +/- 2 days before inclusion : corticosteroid, pancreatic extracts, antisecretory drugs...

结局指标

主要结局

measure glycoprotein-like DMBT1 by Elisa

时间窗: at 1 months

DMBT1 in mg DMBT1 / mg of total protein measured by BCA (BiCinchoninic acid Assay) present in each sputum

次要结局

  • measure MUC5B by Elisa(at 1 months)

研究者

发起方
University Hospital, Lille
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验